Stryker Corporation (SYK)
Add to Watchlists Create an AlertSYK Key Stats
| Income Statement | |
| Revenue TTM | 8.686B |
| Revenue Quarterly YoY Growth | 1.34% |
| EPS Diluted TTM | 3.266 |
| EPS Diluted Quarterly YoY Growth | -13.19% |
| Net Income TTM | 1.252B |
| Profitability | |
| Gross Profit Margin Quarterly | 67.44% |
| Profit Margin Quarterly | 13.88% |
| Dividend | |
| Dividend Yield | 1.58% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 25.43B |
| Enterprise Value | 23.88B |
| PE Ratio TTM | 20.60 |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | 3.008 |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | 0.3278 |
| Free Cash Flow | 187.00M |
| Return on Equity | 15.13% |
SYK News
- Stryker Corporation Stock Buy Recommendation Reiterated (SYK) 6:01 AM
- Stryker Reaches New 52-Week High (SYK) May 22
- Stryker to Present at Investor Conference Thomson Reuters ONE May 20
- July Options Now Available For Stryker (SYK) May 20
- Stryker Reiterated at Neutral May 17
- Stryker Reiterated at Neutral - Analyst Blog Zacks May 17
- SunTrust Robinson Humphrey Downgrades Stryker (SYK) to Reduce Street Insider May 17
- Stryker downgraded to Reduce from Neutral at SunTrust May 17
- How Safe Are Our Dividends In A Troubled Market? May 16
- [video] Amid Rally Some Money Managers Worry About Risks From Abroad May 15
SYK Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Stryker Corporation is up 32.25% over the last year vs S&P 500 Total Return up 28.33%, Zimmer up 34.43%, and Smith & Nephew up 30.89%.
SYK Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these SYK related companies
Pro Ratings for SYK
Pro Report PDF for SYK
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.
Download SYK Pro Report PDF
Pro Strategies Featuring SYK
Did Stryker Corporation make it into our Pro Portfolio Strategies?
SYK Profile
Sector: Healthcare
Industry: Medical Devices
Stryker Corporation, is a Kalamazoo, Michigan based medical technology firm which develops and produces medical implants, surgical and imaging technologies, as well as patient handling and emergency medical equipment. Presently, the company is divided into several discrete operational units, each functioning as a separate entity: Stryker Biotech; Stryker Canada; Stryker Communications; Stryker Craniomaxillofacial; Stryker Development; Stryker Endoscopy; Stryker Imaging; Stryker Japan; Stryker Latin America; Stryker MedSurg; Stryker Orthopaedics; and Stryker Spine. The company sells its products through local dealers and direct sales force to doctors, hospitals, and other healthcare facilities, as well as through third-party dealers and distributors in the United States, Europe, the Middle East, Africa, and Japan, Canada, the Pacific region, and the Latin America region. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Other SYK Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| SYK | 67.27 | -0.43 | -0.64% | 25.43B |
